. Optimization of DOPE content in co-liposomal formulations. HEK 293T cells, transfected with the plasmid pEGFP, were treated with lipoplexes of anti-GFP siRNA with DOPE:THnS (2:1) co-liposomes (n = 4,5,6,8,12) 
in 10% FBS containing DMEM. (A) DOPE-TH4S. (B) DOPE-TH5S. (C) DOPE-TH6S. (D) DOPE-TH8S. (E) DOPE-TH12S
. Data depicted here are based on three independent experiments performed in triplicates and statistical significance was computed in comparison to untreated cells (*P<0.1, **P < 0.01 and ***P <0.001, Student's t test). 
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